Home > Products > Warin
Share Print This Page

Warin (Warfarin)
Therapeutic Group: Cardiovascular » Anti Coagulant

Each tablet contains 5 mg of Warfarin Sodium USP.

Warin is an anticoagulant that acts by inhibiting the synthesis of vitamin K dependent clotting factors, which include Factors II, VII, IX and X. Anticoagulant effect generally occurs within 24 hours after drug administration. This reaches a maximum in 36 - 48 hours and is maintained for 48 hours or more after administration is stopped.
Warin is indicated in the following conditions;

1. Prophylaxis and/or treatment of thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement;

2. Indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction;

3. Prophylaxis and treatment of venous thrombosis and pulmonary embolism;

4. Transient ischaemic attacks.
Dosage & Administration
Whenever possible, the baseline prothrombin time should be determined but the initial dose should not be delayed whilst awaiting the result.
The usual adult induction dose of warfarin is 10 mg daily for 2 days. The subsequent maintenance dose depends upon the prothrombin time, reported as INR (international normalized ratio). The daily maintenance dose of warfarin is usually 3 to 9 mg (taken at the same time each day). The maintenance dose is omitted if the prothrombin time is excessively prolonged. Once the maintenance dose is established in the therapeutic range, it is rarely necessary to alter. In emergencies, anticoagulant therapy should be initiated with heparin and warfarin together. Where there is less urgency, as in patients disposed to or at special risk of thromboembolism, anticoagulant therapy may be initiated with warfarin alone. Control tests must be made at regular intervals and maintenance dosage further adjusted according to the results obtained.
Use in children
Safety and efficacy in children <18 years old have not been established. However, there is evidence of use and the initial dose is usually 0.1 mg.kg-1.d-1 adjusted subsequently to aim for an INR range the same as in adults.
Side Effects
Hemorrhage is the principal adverse effect of oral anticoagulants. Other adverse reactions include nausea, vomiting, diarrhea, hypersensitivity, rash, alopecia, and unexplained drop in haematocrit, "purple toes", skin necrosis, jaundice, and hepatic dysfunction.
Periodic determination of prothrombin time (PT)/international normalized ratio (INR) or other suitable coagulation test is essential. Numerous factors, alone or in combination, including travel, changes in diet, environment, physical state and medication may influence response of the patient to anticoagulants. It is generally good practice to monitor the patient's response with additional PT/INR determination in the period immediately after discharge from the hospital, and whenever other medications are initiated, discontinued or taken irregularly. The following factors may exaggerate the effects of warfarin and necessitate a reduction in dosage; loss of weight, elderly subject, acute illness, deficient renal function, decreased dietary intake of vitamin K, administration of certain drugs (see drug interaction). Factors which may call for an increase in maintenance dosage include weight gain, diarrhea and vomiting, increased intake of vitamin K, fats and oils, and the administration of certain drugs (see drug interaction). Careful additional laboratory control is necessary if the patient is to be changed from one formulation to another. Reversal of warfarin anticoagulation by vitamin K takes several days. In emergency situations fresh frozen plasma should be given.
1. Actual or potential haemorrhagic conditions, eg. Peptic ulcer, or to patients with uncontrolled hypertension
2. Severe hepatic or renal disease
3. Pregnancy
4. Known hypersensitivity to warfarin
5. Bacterial endocarditis
Its use within 24 hours following surgery or labour should be undertaken with caution, if at all.
Use in Pregnancy & Lactation
Warfarin is contraindicated in the first trimester of pregnancy because of the risk of teratogenicity. It should not be used in women who are or may become pregnant because the drug passes through the placental barrier and may cause fatal hemorrhage to the fetus. Warfarin appears in the milk of nursing mothers in an inactive form. Infants nursed by mothers treated with Warfarin had no change in prothrombin times. Effects in premature infants have not been evaluated.
Drug Interaction
Oral anticoagulants have a greater potential for clinically significant drug interactions. Warn all patients about potential hazards and instruct against taking any drug, including non-prescription products, without the advice of a physician.
If hemorrhage occurs or a potential bleeding state arises, excessive depression of the coagulation activity can be corrected by temporary withdrawal of warfarin accompanied, if necessary, by infusion of fresh-frozen plasma or whole blood. Vitamin K, 5 to 10 mg orally or intravenously, may be required to supplement specific treatment with factor concentrates.
Replace cap securely and protect from light.
Commercial Packaging
Warin : Each Box contains 10 strips of 10 tablets.
Products from the same therapeutic group
Anti Anginal
Trimetazidine Dihydrochloride tablet
Ivabradine Hydrochloride
Ranolazine 500 mg
Nitroglycerin 2.6 mg Capsule & Tablet
Trocer Spray
Nitroglycerin 0.4 mg Spray
Anti Coagulant
Enoxaparin Sodium BP
Rivaroxaban 10 & 15 mg Tablet
Warfarin tablet
Anti Fibrinolytic
Tranexamic acid BP
Anti Hypertensive
ARB Plain
Losartan Potassium Tablet
Valsartan tablet
Olmesartan Medoxomil 20 mg Tablet
ACE Inhibitor Plain
Ramipril tablet
ACE Inhibitor Combination
Indapamide and Perindopril Erbumine
Ramoril Plus
Ramipril & Hydrochlorothiazide Tablet
Carvedilol 6.25, 12.5 & 25 mg tablet
Metoprolol tartrate
Bisoprolol Fumarate 2.5 & 5 mg Tablet
Calcium Channel Blocker
Lercanidipine Hydrochloride film-coated tablet
Verapamil hydrochloride
Amlodipine tablet
Centrally Acting Antihypertensive
Combined Antihypertensive Preparations
Amlodipine plus Atenolol tablet
Osartil Plus
Losartan Potassium & Hydrochlorothiazide Tablet
Amlodipine & Valsartan tablet
Valsartil Plus
Valsartan & Hydrochlorothiazide tablet
Xyotil Plus
Olmesartan Medoxomil plus Hydrochlorothiazide
Bisopro Plus
Bisoprolol fumarate and Hydrochlorothiazide tablet
Hydrochlorothiazide tablet
Frusemide & Spironolactone Tablet
Indapamide 1.5 mg Tablet
Eplerenone 25 mg Tablet
Spironolactone 25 mg Tablet
Anti Platelet
Eptifibatide INN
Clopidogrel tablet
Lopirel Plus
Clopidogrel & Aspirin Tablet
Prasugrel Hydrochloride INN tablet
Ticagrelor 90 mg Tablet
Lipid Lowering
Fenofibrate Capsule
Ridel  ER
Niacin USP 500 mg Extended Release tablet
Rosuvastatin 5 & 10 mg Tablet
Atorvastatin 10 mg and Amlodipine 5 mg
Atorvastatin 10, 20 & 40 mg tablet
Sympathomimetics / Inotropes
Adrenaline 1 mg/ml IV, IM, SC injection
Dobutamine Hydrochloride USP
Dopamine Hydrochloride BP Injection